Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Jul;7(4):187-189.

Intravenous Lidocaine Infusions Relieve Chronic Abdominal Pain: Case Report

Affiliations
  • PMID: 40957028
Free article
Case Reports

Intravenous Lidocaine Infusions Relieve Chronic Abdominal Pain: Case Report

Danielle Levin et al. Pain Med Case Rep. 2023 Jul.
Free article

Abstract

Background: Endometriosis is a debilitating disease that presents with chronic pelvic pain, dysmenorrhea, dyspareunia, and infertility. Treatment methods include surgery, no treatment, or medical therapy, commonly including nonsteroidal anti-inflammatory drugs, oral contraceptives, androgenic agents, progestins, and gonadotropin-releasing hormone analogs. Unfortunately, many of these patients have pelvic pain refractory to conventional medical treatment. Intravenous (IV) lidocaine infusions have been studied extensively for neuropathic pain, but there is no report available in regards to whether it could be beneficial for those afflicted with chronic pelvic pain secondary to endometriosis.

Case report: We would like to share the first report of a 37-year-old woman with chronic refractory abdominal pain from endometriosis continuously receiving greater than 3 weeks of pain relief from IV lidocaine infusions.

Conclusions: This case report demonstrates that IV lidocaine infusions may be an effective and safe treatment option for those suffering from chronic abdominal pain from endometriosis.

Keywords: Lidocaine infusions; abdominal pain; chronic pain; endometriosis; lidocaine.

PubMed Disclaimer

Conflict of interest statement

Each author certifies that he or she, or a member of his or her immediate family, has no commercial association (i.e., consultancies, stock ownership, equity interest, patent/licensing arrangements, etc.) that might pose a conflict of interest in connection with the submitted manuscript.

Publication types

LinkOut - more resources